These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 13896331)

  • 1. Frequent human isolation of Serratia marcescens. Bacteriological and pathogenicity studies of twelve strains of S. marcescens recovered from nine patients during a six-month period.
    GALE D; SONNENWIRTH AC
    Arch Intern Med; 1962 Apr; 109():414-21. PubMed ID: 13896331
    [No Abstract]   [Full Text] [Related]  

  • 2. [A new culture medium for Serratia marcescens].
    WEISGLASS H
    Hig Cas Hig Mikrobiol Epidemiol Sanit Teh; 1959; 11():42-4. PubMed ID: 13843683
    [No Abstract]   [Full Text] [Related]  

  • 3. Selection of thermostable Serratia marcescens from logarithmic-phase cultures as a means for inducing synchronous growth.
    HESS GE; SHON M
    J Bacteriol; 1962 Apr; 83(4):781-4. PubMed ID: 13906992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The red pigment prodigiosin is not an essential virulence factor in entomopathogenic Serratia marcescens.
    Zhou W; Li J; Chen J; Liu X; Xiang T; Zhang L; Wan Y
    J Invertebr Pathol; 2016 May; 136():92-4. PubMed ID: 27000435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of putative virulence factors of Serratia marcescens strain SEN for pathogenesis in Spodoptera litura.
    Aggarwal C; Paul S; Tripathi V; Paul B; Khan MA
    J Invertebr Pathol; 2017 Feb; 143():115-123. PubMed ID: 27993620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virulence factors of the human opportunistic pathogen Serratia marcescens identified by in vivo screening.
    Kurz CL; Chauvet S; Andrès E; Aurouze M; Vallet I; Michel GP; Uh M; Celli J; Filloux A; De Bentzmann S; Steinmetz I; Hoffmann JA; Finlay BB; Gorvel JP; Ferrandon D; Ewbank JJ
    EMBO J; 2003 Apr; 22(7):1451-60. PubMed ID: 12660152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on pigmentation of Serratia marcescens. V. Accumulation of pigment fractions with respect to length of incubation time.
    WILLIAMS RP; GOTT CL; GREEN JA
    J Bacteriol; 1961 Mar; 81(3):376-9. PubMed ID: 13785512
    [No Abstract]   [Full Text] [Related]  

  • 8. Serratia marcescens.
    Hejazi A; Falkiner FR
    J Med Microbiol; 1997 Nov; 46(11):903-12. PubMed ID: 9368530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical relevance and virulence factors of pigmented Serratia marcescens.
    Carbonell GV; Della Colleta HH; Yano T; Darini AL; Levy CE; Fonseca BA
    FEMS Immunol Med Microbiol; 2000 Jun; 28(2):143-9. PubMed ID: 10799805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virulence factors in Serratia marcescens: cell-bound hemolysin and aerobactin.
    Carbonell GV; Vidotto MC
    Braz J Med Biol Res; 1992; 25(1):1-8. PubMed ID: 1304938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [PATHOGENICITY OF SERRATIA MARCESCENS OR CHROMOBACTERIUM PRODIGIOSUM].
    BRZIN B
    Zdrav Vestn; 1964; 33():382-3. PubMed ID: 14292685
    [No Abstract]   [Full Text] [Related]  

  • 12. An antimicrobial protein of the Riptortus pedestris salivary gland was cleaved by a virulence factor of Serratia marcescens.
    Lee DJ; Lee JB; Jang HA; Ferrandon D; Lee BL
    Dev Comp Immunol; 2017 Feb; 67():427-433. PubMed ID: 27555079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serratia marcescens internalization and replication in human bladder epithelial cells.
    Hertle R; Schwarz H
    BMC Infect Dis; 2004 Jun; 4():16. PubMed ID: 15189566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenicity of pan-drug-resistant Serratia marcescens harbouring blaNDM-1.
    Gruber TM; Göttig S; Mark L; Christ S; Kempf VA; Wichelhaus TA; Hamprecht A
    J Antimicrob Chemother; 2015 Apr; 70(4):1026-30. PubMed ID: 25468904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotic susceptibility of Serratia marcescens and Serratia liquefaciens.
    Traub WH
    Chemotherapy; 2000; 46(5):315-21. PubMed ID: 10965096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phytosynthesized silver nanoparticles as antiquorum sensing and antibiofilm agent against the nosocomial pathogen Serratia marcescens: an in vitro study.
    Ravindran D; Ramanathan S; Arunachalam K; Jeyaraj GP; Shunmugiah KP; Arumugam VR
    J Appl Microbiol; 2018 Jun; 124(6):1425-1440. PubMed ID: 29431875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of quorum sensing-mediated virulence in Serratia marcescens by Bacillus subtilis R-18.
    Devi KR; Srinivasan S; Ravi AV
    Microb Pathog; 2018 Jul; 120():166-175. PubMed ID: 29660523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Investigation of three nosocomial outbreaks of Serratia marcescens in an intensive care unit in Sfax-Tunisia].
    Ktari S; Mahjoubi F; Mnif B; Kallel H; Bouaziz M; Hammami A
    Tunis Med; 2010 Jul; 88(7):501-6. PubMed ID: 20582888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance-plasmid- and protease-independent murine virulence of a multiple-drug-resistant strain of Serratia marcescens.
    Traub WH; Spohr M; Bauer D
    Zentralbl Bakteriol Mikrobiol Hyg A; 1983 Dec; 256(2):184-95. PubMed ID: 6369833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [On some features of the growth of Bact. prodigiosum in the presence of blood serum of patients with stomach cancer].
    VERKHOLOMOV EE
    Vopr Onkol; 1960; 6(12)():43-7. PubMed ID: 13780910
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.